Thousand Oaks Biopharmaceuticals appeared to be the Corporate Investor, which was created in 2017. The venture was found in Asia in China. The main office of represented Corporate Investor is situated in the Haimen.
The typical case for the fund is to invest in rounds with 8 participants. The meaningful sponsors for the fund in investment in the same round are Yuce Biological Technology, Shenzhen Capital Group, SDIC Venture Capital.
The fund is constantly included in less than 2 investment rounds annually. Deals in the range of 50 - 100 millions dollars are the general things for fund. The important activity for fund was in 2019.
Among the most popular fund investment industries, there are Non Profit, Association. Among the various public portfolio startups of the fund, we may underline MabPlex International For fund there is no match between the country of its foundation and the country of its the most frequent investments - United States. Moreover, a startup needs to be at the age of 6-10 years to get the investment from the fund.
Related Funds
Fund Name | Location |
BankDhofar | Muscat, Muscat, Oman |
BGS Venture | Canada, Ontario, Toronto |
Canon Ball | - |
Chongda Touzi | China, Shanghai |
Digital Century Capital | New York, New York, United States |
First Serve Partners | Boca Raton, Florida, United States |
Gannett Fleming | Camp Hill, Pennsylvania, United States |
Innvotec | England, London, United Kingdom |
MEIF Proof-of-Concept & Early Stage Fund | - |
PICC Health Insurance | Beijing, Beijing Shi, China |
Pingheng Ziben | China, Jiangsu, Nanjing |
Plymouth Growth Partners | Ann Arbor, Michigan, United States |
Provident Capital | Gurgaon, Haryana, India |
SDVentures | New York, New York, United States |
Spok Holdings | Springfield, United States, Virginia |
tarent AG | - |
Tourne View Ventures | New York, New York, United States |
Wealth Club | Bristol, England, United Kingdom |
WND Ventures | California, Redwood City, United States |
Notable deals
Company | Industry | Round Size | Date | Investors | Location |
MabPlex International | $61M | 17 Jan 2019 | Fremont, California, United States |
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Latest deals
Company | Industry | Round Size | Date | Investors | Location |
MabPlex International | $61M | 17 Jan 2019 | Fremont, California, United States |